loading

Loading...

The Trifecta of Mutually-Beneficial Relationships: KOLs, Pharma and Patients—Part One

Now more than ever, pharmaceutical companies’ relationships with physician thought leaders, also known as key opinion leaders (KOLs), are under intense scrutiny. Industry ethicists and watchdogs alike have speculated on the objectivity of medical education presentations and other aspects of[...]

Thought Leader Select Part of a New Wave of Pharma Partners

An interesting article popped up this week in PharmaLive’s Product Marketing Weekly.  Highlighting a new wave of external partners defining Pharma 3.0, the article focused on the effects of downsizing in the industry, and how pharmaceutical companies, now more than[...]

The Numbers Don't Lie: The Global Impact of Thought Leader Select

Since 2005, Thought Leader Select has profiled over 4800 key opinion leaders and over 300 centers of excellence in the field of healthcare. The scope of our 72 completed research projects spans four continents—North America, Europe, Africa, and Asia. We[...]

Welcome to Our Blog!

Welcome to the Thought Leader Select Blog.  As we seek new ways to connect with our client companies and provide a more valuable experience with Thought Leader Select, our blog will serve as a venue for providing information about our[...]